ADIPOQ and metabolic dysfunction-associated steatotic liver disease: In conclusion, L. reuteri MJM60668 can positively improve gut microbiota dysbiosis, markedly inhibit the inflammation characteristic of non-alcoholic fatty liver disease, and significantly inhibit adipogenesis by regulating serum adiponectin levels in treated mice.